NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026)
NeuroPace (NPCE) posted quarterly Amortization of Deferred Charges of $68000.0 for Q1 2026, up 38.78% year-over-year from $49000.0 in Q1 2025, and up 106.6% quarter-over-quarter from -$1.0 million in Q4 2025.
NeuroPace (NPCE) Amortization of Deferred Charges (2020 - 2026) Analysis & Trends
NeuroPace's Amortization of Deferred Charges history runs 7 years deep, the most recent figure standing at $68000.0 for Q1 2026.
- In Q1 2026, Amortization of Deferred Charges rose 38.78% year-over-year to $68000.0; the TTM figure through Mar 2026 stood at -$863000.0 (down 232.36% YoY), while the FY2025 annual figure was $237000.0, down 84.83% from the prior year.
- Amortization of Deferred Charges for Q1 2026 stood at $68000.0, up from -$1.0 million in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $403000.0 in Q4 2024, with the low at -$1.8 million in Q4 2022.
- The 5-year median for Amortization of Deferred Charges is $100000.0 (2022), against an average of -$44187.5.
- The sharpest annual moves came in 2022 and 2024: Amortization of Deferred Charges sank 782.0% in 2022, then jumped 430.26% in 2024.
- NeuroPace's Amortization of Deferred Charges stood at -$1.8 million in 2022, then soared by 104.31% to $76000.0 in 2023, then surged by 430.26% to $403000.0 in 2024, then plunged by 355.83% to -$1.0 million in 2025, then soared by 106.6% to $68000.0 in 2026.
- Business Quant data shows NPCE's Amortization of Deferred Charges at $68000.0 in Q1 2026, -$1.0 million in Q4 2025, and $100000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | NeuroPace | 479.51 Mn | 427.81 Mn | 18.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 100,000.00 |
| Jun 30, 2026 | 100,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Mar 31, 2026 | 68,000.00 |
| Dec 31, 2025 | -1.03 Mn |
| Dec 31, 2025 | -1.03 Mn |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Dec 31, 2024 | 403,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Mar 31, 2024 | 378,000.00 |
| Dec 31, 2023 | 76,000.00 |
| Dec 31, 2023 | 76,000.00 |